about
High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancersRegulation of immune responses by prostaglandin E2COX-2 and PGE2-dependent immunomodulation in breast cancerTargeting inflammation: multiple innovative ways to reduce prostaglandin E₂Prostaglandins and cancerBiosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acidMutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathyThe eosinophil chemoattractant 5-oxo-ETE and the OXE receptorProstaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARγ activity15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerTargeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruitInhibition of immune responses and related proteins in Rhamdia quelen exposed to diclofenac.Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanismsIn-vitro Wound Healing Effect of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor from Plant.Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice.Restoration of leukotriene B(4)-12-hydroxydehydrogenase/15- oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo.Hypoxia activates 15-PGDH and its metabolite 15-KETE to promote pulmonary artery endothelial cells proliferation via ERK1/2 signalling.Crucial role of macrophage selenoproteins in experimental colitis.Analysis of lead toxicity in human cells15-Oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways.Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun.Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology.15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids.Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development.Giant ectopic liver, hepatocellular carcinoma and pachydermia-a rare genetic syndrome?The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache.Resolvins and protectins in inflammation resolution.Intestinal mucus-derived nanoparticle-mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice.Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Celecoxib Treatment.Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm.Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.15-hydroxyprostaglandin dehydrogenase is upregulated by hydroxychloroquine in rheumatoid arthritis fibroblast-like synoviocytesCyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancerCiglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cellsResolvin D1 and resolvin D2 govern local inflammatory tone in obese fatLimited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue.
P2860
Q21136072-3BAE0A84-B67B-4B65-9BB7-083F7723F118Q24318523-78664D2A-59FB-4A33-9C3D-C644BAF9470AQ26849305-05E94DAA-D8F5-4E54-BDE2-788508D57922Q27003937-0A192996-5490-42B1-B3B5-E6AF6DD97682Q27008521-8537DD10-0D90-4AC8-9970-299A57D3487EQ28188827-0ADFE72A-AE92-44DF-B8F1-C1076F638B6EQ28252674-F2B0AB6C-BC49-4074-B27F-DC89C870412DQ28281228-A54A744E-274E-4D4D-8DB5-3C32C60611C4Q28298968-7DFC2743-E43E-4DFC-9C67-78ED606212E0Q28509544-F083815E-FA6E-4575-8908-D10F27675413Q28592082-8DC8DA33-4FB1-41DE-83E2-0193362B21FCQ30573518-A9EF9E29-62F2-41F5-87EE-9B0E6C3D03E6Q31155555-A38F5158-92C7-41E5-B2D3-5399DF4EC2B9Q33581564-EBA53E63-DB07-4219-83CE-F0F88CCB9DCDQ33609153-5BB0F315-D73C-47F7-8CF7-9BADA47694E1Q33685598-E47A33BB-142B-484C-9C8E-A52EE9FC6589Q33759512-0C9A8E1A-8839-45B0-AFCA-34C718AB7BA7Q33929749-838651D6-A369-449F-8FD2-A0C035414800Q34218777-16D1A4C0-ACC1-4EEE-AEDC-232A1625BD8BQ34354516-18DF02E8-A624-4F56-9C1C-BCC32B1F4321Q34450882-674595C7-D14C-46B6-9DCB-D512909E3488Q34462544-843749ED-0191-4099-90F8-81AB341C66E6Q34494513-16700964-E0D3-493A-B8F9-5F8363FA383FQ34952213-A3E13E7B-4FFC-4C76-A43C-C1FF0F8286F6Q35033202-06A6EFC6-AED5-46EB-AC87-BC043ECD943AQ35126717-2862D74B-108A-4CA0-B3D9-146829256AF3Q35138248-63C670B5-6D66-42B8-B70B-373D247C25BAQ35183254-C76D5F46-D906-4EEA-BAF4-FA8A1DF08657Q35214562-0E5C12E4-ED5B-420F-B772-12B8F6C71BC1Q35332873-B2D93A55-23E0-4D65-811C-5430C7531A9DQ35552440-7C85A680-EAD3-45E7-803F-EFE9594EF63CQ35581048-75E639C8-5291-4DA6-8A31-024484E01BDAQ35581635-DACB03CF-D078-4BF4-A0A7-1759718D55FEQ35749972-5920A65B-17F9-437F-B983-EC7D07D11636Q35870151-98DF6991-F152-45E9-87E7-48E911CA8926Q35919681-7E90DF41-F47F-479E-9AA3-7B9F49A087F0Q35929848-AA40FF7C-FFC6-43FE-9D73-380B07782842Q36099516-915A93A8-8588-4A9B-B79F-AE2D191AF234Q36179560-75118EDB-8B44-421D-970B-077B9D3638D1Q36246027-8941F7A3-0858-4692-AF2F-D0B3C898AD27
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prostaglandin catabolizing enzymes.
@ast
Prostaglandin catabolizing enzymes.
@en
Prostaglandin catabolizing enzymes.
@nl
type
label
Prostaglandin catabolizing enzymes.
@ast
Prostaglandin catabolizing enzymes.
@en
Prostaglandin catabolizing enzymes.
@nl
prefLabel
Prostaglandin catabolizing enzymes.
@ast
Prostaglandin catabolizing enzymes.
@en
Prostaglandin catabolizing enzymes.
@nl
P2093
P921
P1476
Prostaglandin catabolizing enzymes.
@en
P2093
Charles Mark Ensor
Fengxiang Yan
Hsin-Hsiung Tai
Huiping Zhou
P304
P356
10.1016/S0090-6980(02)00050-3
P577
2002-08-01T00:00:00Z